A Review of the Safety and Adverse Event Profile of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide
Crossref DOI link: https://doi.org/10.1007/s13300-018-0547-5
Published Online: 2018-12-11
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Frias, Juan P.
Dex, Terry
Roberts, Michelle
Kaplan, Allen
Funding for this research was provided by:
Sanofi
Article History
Received: 28 September 2018
First Online: 11 December 2018